Clinical Trials Directory

Trials / Completed

CompletedNCT05940025

Multidisciplinary Digital Therapeutics of Chronic Lower Back Pain Versus Usual Care

Multidisciplinary Digital Therapeutics for Chronic Low Back Pain Versus In-person Education Combined With Physiotherapy, a Randomized Controlled Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
EverEx Inc. · Industry
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled pilot study will be evaluating an app, MORT-LBP app (ETH-02K), owned by EverEx, Inc., to examine safety and efficacy in individuals with chronic lower back pain.

Detailed description

This randomized controlled pilot study will enroll 46 participants, where half will be randomly assigned to the app, MORT-LBP (n = 23), and half will be assigned to treatment as usual (TAU) (n = 23), to examine safety and efficacy in individuals with chronic lower back pain. All subjects will be followed up in the study for a total of 12 weeks, 8-week courses of treatment with additional 4-week observation. The app provides multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioural therapy for patients with chronic lower back pain.

Conditions

Interventions

TypeNameDescription
DEVICEMORT-LBPThe MORT-LBP, developed by EverEx, Inc., is designed to provide multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioral therapy for patients with chronic lower back pain.
OTHERtreatment as usual (TAU)In the control group, education and physiotherapy is delivered and self-exercise is recommended.

Timeline

Start date
2023-08-16
Primary completion
2024-04-04
Completion
2024-04-04
First posted
2023-07-11
Last updated
2024-07-31

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05940025. Inclusion in this directory is not an endorsement.